Please login to the form below

Not currently logged in
Email:
Password:

HTA

This page shows the latest HTA news and features for those working in and with pharma, biotech and healthcare.

EFPIA-EURORDIS joint statement published on patient access to medicines for rare diseases

EFPIA-EURORDIS joint statement published on patient access to medicines for rare diseases

A number of proposals are also included, supported by both EFPIA and EURORDIS, that aim to improve pricing and reimbursement processes and Health Technology Assessment (HTA), at both EU and member

Latest news

More from news
Approximately 33 fully matching, plus 153 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 14 fully matching, plus 68 partially matching documents found.

Latest appointments

  • Open Access Consulting appoints new director Open Access Consulting appoints new director

    value dossiers, payer-focused objection handlers, stand-alone payer value propositions and local HTA submissions.

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He becomes its new HTA director. AstraZeneca’s former global price and reimbursement director Claes Buxfeldt has joined the NDA advisory board. ... Buxfeldt’s new role at NDA will see him drive and develop the group’s service offerings in the HTA

  • Professor Carole Longson moves from NICE to the ABPI Professor Carole Longson moves from NICE to the ABPI

    She most recently spent the 18 years at the National Institute for Health and Care Excellence ( NICE), where she has led the HTA organisation’s technology appraisal programme.

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support.

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 10 fully matching, plus 24 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...